- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05369143
The Effects of Chiropractic Care and Children With Subclinical Spinal Pain
The Effects of Chiropractic Care on Neurophysiological Function Immune Markers and Health Related Quality of Life in Children With Subclinical Spinal Pain Using Artificial Intelligence Modelling
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rawalpindi, Pakistan
- Mera Ghar Orphan House
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged between 10 and 18 years
- have subclinical spinal pain
Exclusion Criteria:
- no evidence of spinal dysfunction is present
- they are in current pain (above 3/10 on VAS)
- have sought previous treatment for their spinal issues
- are unable to perform the assessment procedures due to contraindications or movement limitations
- diagnosed immune dysfunction
- utilizing a prescribed immunosuppressive medication
- have uncontrolled asthma
- nasal polyps
- use of an intranasal steroid spray one month or less before the study
- are HIV-positive
- are participating in another research study at the time of data collection
- have any diagnosed comorbidity or concomitant disease
- have allergies to yeast or yeast-derived products
- have chronic sinusitis or recent (within the last six weeks) episode of acute sinusitis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Chiropractic care Group
A registered chiropractor will assess the entire spine, and both sacroiliac joints will be assessed for vertebral subluxation by a registered chiropractor with at least five years of clinical experience.The clinical indicators that will be used to assess the function of the spine before spinal adjustment intervention include assessing for joint tenderness to palpation manually palpating for a restricted intersegmental range of motion, assessing for palpable asymmetric intervertebral muscle tension, and any abnormal or blocked joint play and end-feel of the joints.
Chiropractors use these biomechanical characteristics as clinical indicators of spinal dysfunction and vertebral subluxation.
|
The mechanical properties of chiropractic adjustment have been investigated; and although the actual force applied to the patient's spine depends on the chiropractor, the patient, and the spinal location of the subluxation, the general shape of the force-time history of spinal adjustments is very consistent68 and the duration of the thrust is always less than 200 milliseconds.
|
|
Placebo Comparator: Control Group
The participants head and/or spine will be moved in ways that include passive and active movements, similar to what is done when assessing the spine by a chiropractor.
The control intervention will also include the participants moving into adjustment setup positions similar to how the chiropractor would typically set up a patient with no joint pre-loading or adjustive thrust.
No spinal adjustment will be performed during any control intervention.
This control intervention is not intended to act as a sham treatment session
|
The participants head and/or spine will be moved in ways that include passive and active movements, similar to what is done when assessing the spine by a chiropractor.
The sham intervention will also include the participants moving into adjustment setup positions similar to how the chiropractor would typically set up a patient with no joint pre-loading or adjustive thrust
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional near-infrared spectroscopy (fNIRS)
Time Frame: Base line
|
Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation.
It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time.
It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks (Cognitive tasks).
A baseline assessment of a participant will be done before the start of the intervention.
|
Base line
|
|
Functional near-infrared spectroscopy (fNIRS)
Time Frame: After 6 weeks of intervention
|
Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation.
It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time.
It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks (Cognitive tasks).
Assessment of participants will be repeated after 6 weeks of intervention.
|
After 6 weeks of intervention
|
|
Functional near-infrared spectroscopy (fNIRS)
Time Frame: After 12 weeks of intervention and 16 weeks (4-week follow-up testing in a sub-group of participants. )
|
Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation.
It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time.
It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks (Cognitive tasks).
Assessment of participants will be repeated after 12 weeks of intervention.
|
After 12 weeks of intervention and 16 weeks (4-week follow-up testing in a sub-group of participants. )
|
|
Functional near-infrared spectroscopy (fNIRS)
Time Frame: After 16 weeks of intervention
|
Functional near-infrared spectroscopy (fNIRS) is an optical imaging tool for noninvasive, continuous monitoring of regional blood flow and tissue oxygenation.
It can measure two hemodynamic parameters, both deoxyhemoglobin (HHb) and oxyhemoglobin (HbO2), at the same time.
It reflects changes in regional blood flow to areas of the brain involved in processing functional tasks (Cognitive tasks).
Assessment of participants will be repeated after 16 weeks of intervention.
|
After 16 weeks of intervention
|
|
Heart rate variability
Time Frame: Up to 16 Weeks
|
Heart rate variability (HRV) will be used as an objective assessment of psychological health and stress for the participants.
High HRV is a marker of an adaptable, responsive nervous system that can detect sensory stimuli and appropriately increase or decrease the heart rate based on the needs of the individual.
Low HRV and low parasympathetic activity is associated with chronic pain states, poor cardiovascular health and mood disorders.
Heart Rate will be monitored throughout the session.
Assessment of participants will be continued throughout the intervention.
|
Up to 16 Weeks
|
|
Whole head EEG(sub-cohort of participants)
Time Frame: Base line
|
The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International). The participant will be seated comfortably in a chair with eyes closed throughout the entire recording. We will record a period of resting whole head EEG. We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention. A baseline assessment will be done before applying intervention. |
Base line
|
|
Whole head EEG(sub-cohort of participants)
Time Frame: After 6 weeks of intervention
|
The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International).
The participant will be seated comfortably in a chair with eyes closed throughout the entire recording.
We will record a period of resting whole head EEG.
We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention.
Assessment of participants will be repeated after 6 weeks of intervention.
|
After 6 weeks of intervention
|
|
Whole head EEG(sub-cohort of participants)
Time Frame: After 12 weeks of intervention
|
The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International).
The participant will be seated comfortably in a chair with eyes closed throughout the entire recording.
We will record a period of resting whole head EEG.
We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention.
Assessment of participants will be repeated after 12 weeks of intervention.
|
After 12 weeks of intervention
|
|
Whole head EEG(sub-cohort of participants)
Time Frame: After 16 weeks of intervention
|
The EEG will be recorded from 40-scalp electrodes using the extended 10-20 system montage (Quick-Cap International).
The participant will be seated comfortably in a chair with eyes closed throughout the entire recording.
We will record a period of resting whole head EEG.
We will use standardized low-resolution brain electromagnetic tomography (sLORETA) for the resting EEG to calculate potential changes (Spatio-spectral Analysis) in brain activity and communication post the chiropractic care intervention.
Assessment of participants will be repeated after 16 weeks of intervention.
|
After 16 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spatial working memory (SWM)
Time Frame: Base line
|
Spatial Working Memory requires retention and manipulation of visuospatial information. This self-ordered test has notable executive function demands and provides a measure of strategy as well as working memory error. Outcome measures include errors (selecting boxes that have already been found to be empty and revisiting boxes that have already been found to contain a token) and strategy. Fewer errors mean good spatial working memory and vice versa for more errors. A baseline assessment of a participant will be done before the start of the intervention. |
Base line
|
|
Spatial working memory (SWM)
Time Frame: After 6 weeks of intervention
|
Spatial Working Memory requires retention and manipulation of visuospatial information. This self-ordered test has notable executive function demands and provides a measure of strategy as well as working memory error. Outcome measures include errors (selecting boxes that have already been found to be empty and revisiting boxes that have already been found to contain a token) and strategy. Fewer errors mean good spatial working memory and vice versa for more errors. Assessment of participants will be repeated after 6 weeks of intervention. |
After 6 weeks of intervention
|
|
Spatial working memory (SWM)
Time Frame: After 12 weeks of intervention
|
Spatial Working Memory requires retention and manipulation of visuospatial information. This self-ordered test has notable executive function demands and provides a measure of strategy as well as working memory error. Outcome measures include errors (selecting boxes that have already been found to be empty and revisiting boxes that have already been found to contain a token) and strategy. Fewer errors mean good spatial working memory and vice versa for more errors. Assessment of participants will be repeated after 12 weeks of intervention. |
After 12 weeks of intervention
|
|
Spatial working memory (SWM)
Time Frame: After 16 weeks of intervention
|
Spatial Working Memory requires retention and manipulation of visuospatial information. This self-ordered test has notable executive function demands and provides a measure of strategy as well as working memory error. Outcome measures include errors (selecting boxes that have already been found to be empty and revisiting boxes that have already been found to contain a token) and strategy. Fewer errors mean good spatial working memory and vice versa for more errors. Assessment of participants will be repeated after 16 weeks of intervention. |
After 16 weeks of intervention
|
|
Reaction time (RTI)
Time Frame: Base line
|
Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity. Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants. It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission. More accurate reaction in less time inclines toward good reaction time. A baseline assessment of a participant will be done before the start of the intervention. |
Base line
|
|
Reaction time (RTI)
Time Frame: After 6 weeks of intervention
|
Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity. Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants. It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission. More accurate reaction in less time inclines toward good reaction time. Assessment of participants will be repeated after 6 weeks of intervention. |
After 6 weeks of intervention
|
|
Reaction time (RTI)
Time Frame: After 12 weeks of intervention
|
Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity. Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants. It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission. More accurate reaction in less time inclines toward good reaction time. Assessment of participants will be repeated after 12 weeks of intervention. |
After 12 weeks of intervention
|
|
Reaction time (RTI)
Time Frame: After 16 weeks of intervention
|
Reaction Time provides assessments of motor and mental response speeds and measures of movement time, reaction time, response accuracy, and impulsivity. Outcome measures are divided into reaction time and movement time for both the simple and five-choice variants. It's a six-minute test that covers latency (response speed), correct responses and errors of commission and omission. More accurate reaction in less time inclines toward good reaction time. Assessment of participants will be repeated after 16 weeks of intervention. |
After 16 weeks of intervention
|
|
Paired Associate Learning (PAL)
Time Frame: Base line
|
Paired Associates Learning assesses visual memory and new learning Outcome measures include the errors made by the participant, the number of trials required to locate the pattern(s) correctly, memory scores and stages completed.
A baseline assessment of a participant will be done before the start of the intervention.
|
Base line
|
|
Paired Associate Learning (PAL)
Time Frame: After 6 weeks of intervention
|
Paired Associates Learning assesses visual memory and new learning Outcome measures include the errors made by the participant, the number of trials required to locate the pattern(s) correctly, memory scores and stages completed.
Assessment of participants will be repeated after 6 weeks of intervention.
|
After 6 weeks of intervention
|
|
Paired Associate Learning (PAL)
Time Frame: After 12 weeks of intervention
|
Paired Associates Learning assesses visual memory and new learning Outcome measures include the errors made by the participant, the number of trials required to locate the pattern(s) correctly, memory scores and stages completed.
Assessment of participants will be repeated after 12 weeks of intervention.
|
After 12 weeks of intervention
|
|
Paired Associate Learning (PAL)
Time Frame: After 16 weeks of intervention
|
Paired Associates Learning assesses visual memory and new learning Outcome measures include the errors made by the participant, the number of trials required to locate the pattern(s) correctly, memory scores and stages completed.
Assessment of participants will be repeated after 16 weeks of intervention.
|
After 16 weeks of intervention
|
|
Stockings of Cambridge (SoC)
Time Frame: At Baseline
|
Stockings of Cambridge (SOC) is a test of spatial planning that requires individuals to use problem-solving strategies to match two sets of stimuli.
A baseline assessment of a participant will be done before the start of the intervention.
|
At Baseline
|
|
Stockings of Cambridge (SoC)
Time Frame: After 6 weeks of intervention
|
Stockings of Cambridge (SOC) is a test of spatial planning that requires individuals to use problem-solving strategies to match two sets of stimuli. Assessment of participants will be repeated after 6 weeks of intervention. |
After 6 weeks of intervention
|
|
Stockings of Cambridge (SoC)
Time Frame: After 12 weeks of intervention
|
Stockings of Cambridge (SOC) is a test of spatial planning that requires individuals to use problem-solving strategies to match two sets of stimuli.
Assessment of participants will be repeated after 12 weeks of intervention.
|
After 12 weeks of intervention
|
|
Stockings of Cambridge (SoC)
Time Frame: After 16 weeks of intervention
|
Stockings of Cambridge (SOC) is a test of spatial planning that requires individuals to use problem-solving strategies to match two sets of stimuli.
Assessment of participants will be repeated after 16 weeks of intervention.
|
After 16 weeks of intervention
|
|
Delayed Matching to Sample (DMS)
Time Frame: At Baseline
|
Delayed Matching to Sample assesses both simultaneous visual matching ability and short-term visual recognition memory for non-verbalizable patterns.
A baseline assessment of a participant will be done before the start of the intervention.
|
At Baseline
|
|
Delayed Matching to Sample (DMS)
Time Frame: After 6 weeks of intervention
|
Delayed Matching to Sample assesses both simultaneous visual matching ability and short-term visual recognition memory for non-verbalizable patterns.
Assessment of participants will be repeated after 6 weeks of intervention.
|
After 6 weeks of intervention
|
|
Delayed Matching to Sample (DMS)
Time Frame: After 12 weeks of intervention
|
Delayed Matching to Sample assesses both simultaneous visual matching ability and short-term visual recognition memory for non-verbalizable patterns.
Assessment of participants will be repeated after 12 weeks of intervention.
|
After 12 weeks of intervention
|
|
Delayed Matching to Sample (DMS)
Time Frame: After 16 weeks of intervention
|
Delayed Matching to Sample assesses both simultaneous visual matching ability and short-term visual recognition memory for non-verbalizable patterns.
Assessment of participants will be repeated after 16 weeks of intervention.
|
After 16 weeks of intervention
|
|
Health-related quality of life
Time Frame: Base line
|
The health-related quality of life will be measured using the PROMIS Pediatric v2.0 profile 25, which assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain. PROMIS Pediatric v2.0 profile 25 is a reliable and valid instrument that can be used to assess the impacts of health care interventions and track changes in health over time. A baseline assessment of a participant will be done before the start of the intervention. The QOLS is scored by adding up the score on each item to yield a total score for the instrument. Scores can range from 16 to 112. |
Base line
|
|
Health-related quality of life
Time Frame: After 6 weeks of intervention
|
The health-related quality of life will be measured using the PROMIS Pediatric v2.0 profile 25, which assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain. PROMIS Pediatric v2.0 profile 25 is a reliable and valid instrument that can be used to assess the impacts of health care interventions and track changes in health over time. Assessment of participants will be repeated after 6 weeks of intervention. The QOLS is scored by adding up the score on each item to yield a total score for the instrument. Scores can range from 16 to 112. |
After 6 weeks of intervention
|
|
Health-related quality of life
Time Frame: After 12 weeks of intervention
|
The health-related quality of life will be measured using the PROMIS Pediatric v2.0 profile 25, which assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain. PROMIS Pediatric v2.0 profile 25 is a reliable and valid instrument that can be used to assess the impacts of health care interventions and track changes in health over time. Assessment of participants will be repeated after 12 weeks of intervention. The QOLS is scored by adding up the score on each item to yield a total score for the instrument. Scores can range from 16 to 112. |
After 12 weeks of intervention
|
|
Health-related quality of life
Time Frame: After 16 weeks of intervention
|
The health-related quality of life will be measured using the PROMIS Pediatric v2.0 profile 25, which assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain. PROMIS Pediatric v2.0 profile 25 is a reliable and valid instrument that can be used to assess the impacts of health care interventions and track changes in health over time. Assessment of participants will be repeated after 16 weeks of intervention. The QOLS is scored by adding up the score on each item to yield a total score for the instrument. Scores can range from 16 to 112. |
After 16 weeks of intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Saliva Cortisol
Time Frame: Base line
|
Cortisol can alter cytokine levels (such as increasing IL-6 pro-inflammatory cytokines) that then alter the levels of inflammation throughout the body. Cortisol could be measured from saliva samples. Cortisol (otherwise known as the stress hormone) is made in the adrenal glands. It's elevated when we experience heightened anxiety or stress, and it's lowered when we're in a relaxed state. A baseline assessment of a participant will be done before the start of the intervention. |
Base line
|
|
Saliva Cortisol
Time Frame: after 12 weeks of intervention
|
Cortisol can alter cytokine levels (such as increasing IL-6 pro-inflammatory cytokines) that then alter the levels of inflammation throughout the body. Cortisol could be measured from saliva samples. Cortisol (otherwise known as the stress hormone) is made in the adrenal glands. It's elevated when we experience heightened anxiety or stress, and it's lowered when we're in a relaxed state. Assessment of participants will be repeated after 12 weeks of intervention. |
after 12 weeks of intervention
|
|
Saliva Cortisol
Time Frame: after 16 weeks of intervention
|
Cortisol can alter cytokine levels (such as increasing IL-6 pro-inflammatory cytokines) that then alter the levels of inflammation throughout the body. Cortisol could be measured from saliva samples. Cortisol (otherwise known as the stress hormone) is made in the adrenal glands. It's elevated when we experience heightened anxiety or stress, and it's lowered when we're in a relaxed state. Assessment of participants will be repeated after 16 weeks of intervention. |
after 16 weeks of intervention
|
|
Hair Cortisol
Time Frame: Baseline
|
Cortisol can alter cytokine levels (such as increasing IL-6 pro-inflammatory cytokines) that then alter the levels of inflammation throughout the body. Cortisol could be measured from Hair samples. Cortisol (otherwise known as the stress hormone) is made in the adrenal glands. It's elevated when we experience heightened anxiety or stress, and it's lowered when we're in a relaxed state. Assessment of participants will be done at the baseline of the study. |
Baseline
|
|
Hair Cortisol
Time Frame: After 12 weeks of intervention
|
Cortisol can alter cytokine levels (such as increasing IL-6 pro-inflammatory cytokines) that then alter the levels of inflammation throughout the body. Cortisol could be measured from Hair samples. Cortisol (otherwise known as the stress hormone) is made in the adrenal glands. It's elevated when we experience heightened anxiety or stress, and it's lowered when we're in a relaxed state. Assessment of participants will be repeated after 12 weeks of intervention. |
After 12 weeks of intervention
|
|
Immune Function Questionnaire (IFQ)
Time Frame: At baseline
|
The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function. There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries. The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner. A baseline assessment of a participant will be done before the start of the intervention. Calculate the sum score of the 7 IFQ items. To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status. |
At baseline
|
|
Immune Function Questionnaire (IFQ)
Time Frame: After 6 weeks of intervention
|
The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function.
There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries.
The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner.
Assessment of participants will be repeated after 6 weeks of intervention.
Calculate the sum score of the 7 IFQ items.
To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status.
|
After 6 weeks of intervention
|
|
Immune Function Questionnaire (IFQ)
Time Frame: After 12 weeks of intervention
|
The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function.
There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries.
The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner.
Assessment of participants will be repeated after 12 weeks of intervention.
Calculate the sum score of the 7 IFQ items.
To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status.
|
After 12 weeks of intervention
|
|
Immune Function Questionnaire (IFQ)
Time Frame: After 16 weeks of intervention
|
The Immune Function Questionnaire (IFQ) consists of 15 items that assess the frequency of various symptoms associated with poor immune function.
There are 19 symptom items included on the questionnaire as signs of weakened immune system functioning: headaches, sore throat, eye infection, sinusitis, runny nose, flu, coughing, cold sores, boils, mild fever, pneumonia, bronchitis, warts/verrucas, sepsis, ear infection, diarrhea, meningitis, sudden high fever, and prolonged healing injuries.
The IFQ score has been found to positively correlate with the number of visits to a General Medical Practitioner.
Assessment of participants will be repeated after 16 weeks of intervention.
Calculate the sum score of the 7 IFQ items.
To obtain the final IFQ score, translate the "raw" IFQ scores as follows: Interpretation: 0 = very poor, 10 excellent perceived immune status.
|
After 16 weeks of intervention
|
|
Inflammation markers from Fitbit data
Time Frame: Up to 16 Weeks
|
Fitbit can be used to measure the autonomic nervous system (ANS).
Heart rate variability (HRV) has become a validated marker of autonomic function.
In a large population-based study it was found that strong and independent relationships between HR and HRV with a broad set of inflammatory biomarkers.
The recording will be done for up to 16 weeks.
|
Up to 16 Weeks
|
|
Smartphone Gait and Balance Application
Time Frame: Baseline
|
The system consists of the following three components: i) a smartphone that has an embedded accelerometer, ii) a belt to house the phone on the lower back, iii) and a smartphone balance application.
There are six different tasks that the subject has to perform with the system, like, normal walking up to 6 meters, walking with head movement, standing with eyes open and closed and standing on a compromised surface with eyes open and closed.
This app.
will calculate mediolateral and anterior-posterior sway during each task.
Assessment will be done at baseline.
|
Baseline
|
|
Smartphone Gait and Balance Application
Time Frame: After 6 weeks of intervention
|
The system consists of the following three components: i) a smartphone that has an embedded accelerometer, ii) a belt to house the phone on the lower back, iii) and a smartphone balance application.
There are six different tasks that the subject has to perform with the system, like, normal walking up to 6 meters, walking with head movement, standing with eyes open and closed and standing on a compromised surface with eyes open and closed.
This app.
will calculate mediolateral and anterior-posterior sway during each task.
Assessment will be done after 6 weeks.
|
After 6 weeks of intervention
|
|
Smartphone Gait and Balance Application
Time Frame: After 12 weeks of intervention
|
The system consists of the following three components: i) a smartphone that has an embedded accelerometer, ii) a belt to house the phone on the lower back, iii) and a smartphone balance application.
There are six different tasks that the subject has to perform with the system, like, normal walking up to 6 meters, walking with head movement, standing with eyes open and closed and standing on a compromised surface with eyes open and closed.
This app.
will calculate mediolateral and anterior-posterior sway during each task.
Assessment will be done after 12 weeks.
|
After 12 weeks of intervention
|
|
Smartphone Gait and Balance Application
Time Frame: After 16 weeks of intervention
|
The system consists of the following three components: i) a smartphone that has an embedded accelerometer, ii) a belt to house the phone on the lower back, iii) and a smartphone balance application.
There are six different tasks that the subject has to perform with the system, like, normal walking up to 6 meters, walking with head movement, standing with eyes open and closed and standing on a compromised surface with eyes open and closed.
This app.
will calculate mediolateral and anterior-posterior sway during each task.
Assessment will be done after 16 weeks.
|
After 16 weeks of intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: IMRAN KHAN NIAZI, PhD, New Zealand College of Chiropractic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REC/01286 Imran Amjad
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subclinical Spinal Pain
-
Riphah International UniversityCompletedSubclinical Spinal PainPakistan
-
Xinghua LiuNot yet recruitingSubclinical Anxious Adults | Subclinical Depression | Subclinical Emotional DistressChina
-
Assiut UniversityNot yet recruitingSubclinical HypothyroidismEgypt
-
Sheffield Teaching Hospitals NHS Foundation TrustHRA PharmaCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingSubclinical Atherosclerosis
-
Seoul National University Bundang HospitalRecruitingSubclinical HypothyroidismSouth Korea
-
Infanta Leonor University HospitalActive, not recruitingCardiovascular Risk | Subclinical AtherosclerosisSpain
-
Prof. Dominique de Quervain, MDCompletedFear of Public Speaking (Subclinical)Switzerland
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingSubclinical Cardiovascular Impairments | Cardiovascular (CV) Risk | MASLDChina
-
Tanta UniversityRecruitingChildren | Subclinical Hypothyroidism | Cardiac Function | LevothyroxineEgypt
Clinical Trials on Chiropractic care
-
Real Centro Universitario Maria CristinaUniversité du Québec à Trois-Rivières; University of BirminghamCompletedMusculoskeletal Pain | Psychological Distress | Disability PhysicalSpain
-
Life UniversitySuspended
-
Real Centro Universitario Maria CristinaUniversité du Québec à Trois-Rivières; University of Birmingham; Instituto de...Completed
-
Scandinavian College of ChiropracticKarolinska Institutet; Stockholm South General HospitalCompleted
-
Life UniversityNot yet recruitingSensory Processing DisorderUnited States
-
Life UniversityNot yet recruiting
-
Life UniversitySuspended
-
RANDPalmer College of Chiropractic; Samueli Institute for Information BiologyCompletedPhysiological Measurements of Response and Reaction TimesUnited States
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); Berman Center for Outcomes...CompletedSub-Acute and Chronic Low Back PainUnited States
-
Tyson Perez, DC, PhDRecruitingThe Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV (HIV)Human Immunodeficiency Virus (HIV)United States